Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Morbidity Management and Disability Prevention of Lymphatic Filariasis

Sangamithra A, Dhavamani P. Shanlax International Journals. Shanlax International Journal of Economics. 2021; 9 (3) : 24-28.
Download PDF
Publication

How can we achieve impact from public health research? A meta-ethnography of case studies

Gentry SV, Milden L, Kelly MP. Oxford University Press (OUP). Journal of Public Health. 2019; 43 (2) : 370-377.
Publication

ONCHOCERCIASIS: DIAGNOSTIC TARGET PRODUCT PROFILE to support preventive chemotherapy

World Healh Organization . World Health Organization. 2021;
Download PDF
Publication

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?

Vinkeles Melchers NVS, Stolk WA, Murdoch ME, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2021; 15 (6) : e0009489.
Download PDF
Publication

Prospects for employment of persons with disabilities in the post-covid-19 era in developing countries

Morris F. Informa UK Limited. Disability & Society. 2021;
Download PDF
Publication

Bridging the gap: aligning economic research with disease burden.

Do L, Synnott P, Ma S, et al. BMJ global health. 2021;
Download PDF
Publication

COVID-19 and its impacts: The situation in Niger republic.

Nzeribe E, Michael U, Musa S, et al. Clinical epidemiology and global health. 2021;
Download PDF
Publication

Data management plan for a community-level study of the hidden burden of cutaneous leishmaniasis in Colombia

Oviedo Sarmiento OJ, Castro MDM, Lerma YO, et al. Springer Science and Business Media LLC. BMC Research Notes. 2021;
Download PDF
Publication

Primary health care facilities capacity gaps regarding diagnosis, treatment and knowledge of schistosomiasis among healthcare workers in North-western Tanzania: a call to strengthen the horizontal system

Mazigo HD, Uisso C, Kazyoba P, et al. Springer Science and Business Media LLC. BMC Health Services Research. 2021;
Download PDF
Publication

Model building and assessment of the impact of covariates for disease prevalence mapping in low-resource settings: to explain and to predict

Giorgi E, Fronterrè C, Macharia PM, et al. The Royal Society. Journal of The Royal Society Interface. 2021; 18 (179) : 20210104.
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 400
  • Page 401
  • Page 402
  • Page 403
  • Current page 404
  • Page 405
  • Page 406
  • Page 407
  • Page 408
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD